BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 31158416)

  • 1. l-arginine alleviates doxorubicin-induced endothelium-dependent dysfunction by promoting nitric oxide generation and inhibiting apoptosis.
    Li X; Gu J; Zhang Y; Feng S; Huang X; Jiang Y; Xia Y; Liu Y; Yang X
    Toxicology; 2019 Jul; 423():105-111. PubMed ID: 31158416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Doxorubicin induces arterial stiffness: A comprehensive in vivo and ex vivo evaluation of vascular toxicity in mice.
    Bosman M; Favere K; Neutel CHG; Jacobs G; De Meyer GRY; Martinet W; Van Craenenbroeck EM; Guns PDF
    Toxicol Lett; 2021 Aug; 346():23-33. PubMed ID: 33895255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Poly(ADP-ribose) polymerase-2 depletion reduces doxorubicin-induced damage through SIRT1 induction.
    Szántó M; Rutkai I; Hegedus C; Czikora Á; Rózsahegyi M; Kiss B; Virág L; Gergely P; Tóth A; Bai P
    Cardiovasc Res; 2011 Dec; 92(3):430-8. PubMed ID: 21921080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of rosiglitazone in sodium arsenite-induced experimental vascular endothelial dysfunction.
    Kaur T; Goel RK; Balakumar P
    Arch Pharm Res; 2010 Apr; 33(4):611-8. PubMed ID: 20422371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reversal of doxorubicin-induced vascular dysfunction by resveratrol in rat thoracic aorta: Is there a possible role of nitric oxide synthase inhibition?
    Olukman M; Can C; Erol A; Oktem G; Oral O; Cinar MG
    Anadolu Kardiyol Derg; 2009 Aug; 9(4):260-6. PubMed ID: 19666426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergistic interaction between enalapril, L-arginine and tetrahydrobiopterin in smooth muscle cell apoptosis and aortic remodeling induction in SHR.
    Der Sarkissian S; Marchand EL; Duguay D; deBlois D
    Br J Pharmacol; 2004 Jul; 142(5):912-8. PubMed ID: 15197102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tetramethylpyrazine Attenuates the Endotheliotoxicity and the Mitochondrial Dysfunction by Doxorubicin
    Yang B; Li H; Qiao Y; Zhou Q; Chen S; Yin D; He H; He M
    Oxid Med Cell Longev; 2019; 2019():5820415. PubMed ID: 31885804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aspalathin ameliorates doxorubicin-induced oxidative stress in H9c2 cardiomyoblasts.
    Shabalala SC; Dludla PV; Muller CJF; Nxele X; Kappo AP; Louw J; Johnson R
    Toxicol In Vitro; 2019 Mar; 55():134-139. PubMed ID: 30576852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aldose reductase inhibitor, fidarestat prevents doxorubicin-induced endothelial cell death and dysfunction.
    Sonowal H; Pal P; Shukla K; Saxena A; Srivastava SK; Ramana KV
    Biochem Pharmacol; 2018 Apr; 150():181-190. PubMed ID: 29458045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Luteolin reduces high glucose-mediated impairment of endothelium-dependent relaxation in rat aorta by reducing oxidative stress.
    Qian LB; Wang HP; Chen Y; Chen FX; Ma YY; Bruce IC; Xia Q
    Pharmacol Res; 2010 Apr; 61(4):281-7. PubMed ID: 19892019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Time course of changes in oxidative stress and stress-induced proteins in cardiomyocytes exposed to doxorubicin and prevention by vitamin C.
    Ludke A; Akolkar G; Ayyappan P; Sharma AK; Singal PK
    PLoS One; 2017; 12(7):e0179452. PubMed ID: 28678856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arginine attenuates methylglyoxal- and high glucose-induced endothelial dysfunction and oxidative stress by an endothelial nitric-oxide synthase-independent mechanism.
    Dhar I; Dhar A; Wu L; Desai K
    J Pharmacol Exp Ther; 2012 Jul; 342(1):196-204. PubMed ID: 22518022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective effects of Danzhi jiangtang capsule on vascular endothelial damages induced by high-fat diet and palmitic acid.
    Lu Y; Chen Y; Li R; Liu Q; Wang N; Zhang Y; Li B; Fang Z
    Biomed Pharmacother; 2018 Nov; 107():1631-1640. PubMed ID: 30257381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Doxorubicin-induced apoptosis in endothelial cells and cardiomyocytes is ameliorated by nitrone spin traps and ebselen. Role of reactive oxygen and nitrogen species.
    Kotamraju S; Konorev EA; Joseph J; Kalyanaraman B
    J Biol Chem; 2000 Oct; 275(43):33585-92. PubMed ID: 10899161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arginase Inhibition Restores Peroxynitrite-Induced Endothelial Dysfunction via L-Arginine-Dependent Endothelial Nitric Oxide Synthase Phosphorylation.
    Nguyen MC; Park JT; Jeon YG; Jeon BH; Hoe KL; Kim YM; Lim HK; Ryoo S
    Yonsei Med J; 2016 Nov; 57(6):1329-38. PubMed ID: 27593859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uncoupling protein-2 protects endothelial function in diet-induced obese mice.
    Tian XY; Wong WT; Xu A; Lu Y; Zhang Y; Wang L; Cheang WS; Wang Y; Yao X; Huang Y
    Circ Res; 2012 Apr; 110(9):1211-6. PubMed ID: 22461387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allicin ameliorates doxorubicin-induced cardiotoxicity in rats via suppression of oxidative stress, inflammation and apoptosis.
    Abdel-Daim MM; Kilany OE; Khalifa HA; Ahmed AAM
    Cancer Chemother Pharmacol; 2017 Oct; 80(4):745-753. PubMed ID: 28785995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new thiocyanoacetamide (2-cyano-2-p-nitrophenyl-N-benzylthioamide) reduces doxorubicin-induced in vitro toxicity in Sertoli cells by decreasing apoptosis and autophagy.
    Boussada M; Dias TR; Crisóstomo L; Akacha AB; Ali RB; El May MV; Alves MG; Oliveira PF
    Theriogenology; 2019 Dec; 140():188-200. PubMed ID: 31479835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carvedilol (CAR) combined with carnosic acid (CAA) attenuates doxorubicin-induced cardiotoxicity by suppressing excessive oxidative stress, inflammation, apoptosis and autophagy.
    Zhang QL; Yang JJ; Zhang HS
    Biomed Pharmacother; 2019 Jan; 109():71-83. PubMed ID: 30396094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Doxorubicin-induced vascular dysfunction and its attenuation by exercise preconditioning.
    Gibson NM; Greufe SE; Hydock DS; Hayward R
    J Cardiovasc Pharmacol; 2013 Oct; 62(4):355-60. PubMed ID: 23719093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.